pravastatin has been researched along with Hyperglycemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altman, RB; Horvitz, E; Shah, NH; Tatonetti, NP; White, RW | 1 |
| Bussolati, B; Camussi, G; Cavallo Perin, P; Favaro, E; Miceli, I; Schimitt-Ney, M; Schmitt-Ney, M; Zanone, MM | 1 |
| Ito, R; Ito, Y; Itoh, T; Kajikuri, J; Watanabe, Y; Yamamoto, T | 1 |
| Blauw, GJ; Bollen, EL; de Craen, AJ; de Roos, A; Jukema, JW; Middelkoop, HA; van Buchem, MA; van der Grond, J; van Elderen, SG; Westendorp, RG | 1 |
| Fukushima, H; Funahashi, T; Horibata, Y; Koga, H; Kojima, S; Kugiyama, K; Maruyoshi, H; Ogawa, H; Otsuka, F; Sakamoto, T; Shimomura, I; Sugamura, K; Sugiyama, S; Watanabe, K | 1 |
| Arita, S; Kasraie, A; Mullen, Y; Ohtsuka, S; Smith, CV; Une, S | 1 |
2 trial(s) available for pravastatin and Hyperglycemia
| Article | Year |
|---|---|
Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.
Topics: Aged; Aged, 80 and over; Atrophy; Brain; Cognition Disorders; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hypoglycemic Agents; Insulin; Linear Models; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Pravastatin | 2010 |
Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease.
Topics: Adiponectin; Aged; Blood Glucose; Coronary Artery Disease; Female; Glucose Tolerance Test; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Male; Middle Aged; Postprandial Period; Pravastatin | 2007 |
4 other study(ies) available for pravastatin and Hyperglycemia
| Article | Year |
|---|---|
Web-scale pharmacovigilance: listening to signals from the crowd.
Topics: Data Mining; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Information Storage and Retrieval; Internet; Paroxetine; Pharmacovigilance; Pravastatin; Product Surveillance, Postmarketing; ROC Curve; Selective Serotonin Reuptake Inhibitors | 2013 |
Hyperglycemia induces apoptosis of human pancreatic islet endothelial cells: effects of pravastatin on the Akt survival pathway.
Topics: Apoptosis; Caspase 3; Cell Survival; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Interleukin-1beta; Islets of Langerhans; Membrane Proteins; Microcirculation; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphatidylinositol 3-Kinases; Phosphorylation; Pravastatin; Proto-Oncogene Proteins c-akt; Signal Transduction | 2008 |
Characteristic changes in coronary artery at the early hyperglycaemic stage in a rat type 2 diabetes model and the effects of pravastatin.
Topics: Animals; Coronary Vessels; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Male; Nitric Oxide Synthase Type III; Pravastatin; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Superoxides | 2009 |
Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
Topics: Animals; Blood Glucose; Body Weight; Cyclosporine; Drug Synergism; Graft Survival; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Immunosuppressive Agents; Islets of Langerhans Transplantation; Kidney; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pravastatin; Transplantation, Homologous | 2001 |